Abciximab
Ketoprofen may increase the anticoagulant activities of Abciximab.
Abiraterone
The metabolism of Ketoprofen can be decreased when combined with Abiraterone.
Acebutolol
Ketoprofen may decrease the antihypertensive activities of Acebutolol.
Advertisement
Aceclofenac
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Aceclofenac.
Acemetacin
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Acemetacin.
Acenocoumarol
Ketoprofen may increase the anticoagulant activities of Acenocoumarol.
Advertisement
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ketoprofen.
Aclarubicin
Ketoprofen may decrease the excretion rate of Aclarubicin which could result in a higher serum level.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Ketoprofen.
Advertisement
Alclometasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alclometasone.
Aldosterone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Aldosterone.
Alendronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.
Alendronic acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.
Aliskiren
Ketoprofen may decrease the antihypertensive activities of Aliskiren.
Alminoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alminoprofen.
Alprenolol
Ketoprofen may decrease the antihypertensive activities of Alprenolol.
Alprostadil
The therapeutic efficacy of Alprostadil can be decreased when used in combination with Ketoprofen.
Amcinonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Amcinonide.
Amikacin
Ketoprofen may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amiloride
Ketoprofen may decrease the antihypertensive activities of Amiloride.
Amiodarone
The metabolism of Ketoprofen can be decreased when combined with Amiodarone.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Ketoprofen.
Ancrod
Ketoprofen may increase the anticoagulant activities of Ancrod.
Androstenedione
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Androstenedione.
Anhydrous Tacrolimus
Ketoprofen may increase the nephrotoxic activities of Tacrolimus.
Antipyrine
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Antipyrine.
Antithrombin III
Ketoprofen may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Ketoprofen may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Ketoprofen can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Azapropazone.
Apixaban
Ketoprofen may increase the anticoagulant activities of Apixaban.
Apremilast
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Apremilast.
Aprepitant
The metabolism of Ketoprofen can be increased when combined with Aprepitant.
Arbekacin
Ketoprofen may decrease the excretion rate of Arbekacin which could result in a higher serum level.
Ardeparin
Ketoprofen may increase the anticoagulant activities of Ardeparin.
Argatroban
Ketoprofen may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Ketoprofen may increase the anticoagulant activities of Argatroban.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ketoprofen.
Atenolol
Ketoprofen may decrease the antihypertensive activities of Atenolol.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Ketoprofen.
azficel-T
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Azficel-T.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ketoprofen.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ketoprofen.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Ketoprofen.
Azosemide
The therapeutic efficacy of Azosemide can be decreased when used in combination with Ketoprofen.
Balsalazide
Ketoprofen may increase the nephrotoxic activities of Balsalazide.
Becaplermin
Ketoprofen may increase the anticoagulant activities of Becaplermin.
Beclomethasone Dipropionate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Beclomethasone dipropionate.
Benazepril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Benazepril.
Bendroflumethiazide
The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Ketoprofen.
Benzydamine
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Benzydamine.
Betamethasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Betamethasone.
Betaxolol
Ketoprofen may decrease the antihypertensive activities of Betaxolol.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Ketoprofen.
Bimatoprost
The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Ketoprofen.
Bisoprolol
Ketoprofen may decrease the antihypertensive activities of Bisoprolol.
Bivalirudin
Ketoprofen may increase the anticoagulant activities of Bivalirudin.
Bopindolol
Ketoprofen may decrease the antihypertensive activities of Bopindolol.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Ketoprofen.
Budesonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Budesonide.
Bufexamac
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Bufexamac.
Bumetanide
The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ketoprofen.
Bupranolol
Ketoprofen may decrease the antihypertensive activities of Bupranolol.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Ketoprofen.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Ketoprofen.
Capecitabine
The metabolism of Ketoprofen can be decreased when combined with Capecitabine.
Captopril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Captopril.
Carbamazepine
The metabolism of Ketoprofen can be increased when combined with Carbamazepine.
Carboprost
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Ketoprofen.
Carboprost Tromethamine
The therapeutic efficacy of Carboprost Tromethamine can be decreased when used in combination with Ketoprofen.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Ketoprofen.
Carteolol
Ketoprofen may decrease the antihypertensive activities of Carteolol.
Carvedilol
Ketoprofen may decrease the antihypertensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Celecoxib.
Celiprolol
Ketoprofen may decrease the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Ketoprofen can be increased when it is combined with Ceritinib.
Certoparin
Ketoprofen may increase the anticoagulant activities of Certoparin.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Ketoprofen.
Chlorothiazide
The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Ketoprofen.
Chlorthalidone
The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Ketoprofen.
Cholecalciferol
The metabolism of Ketoprofen can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Ketoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Choline magnesium trisalicylate.
Ciclesonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ciclesonide.
Cilazapril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Cilazapril.
Cinoxacin
Ketoprofen may increase the neuroexcitatory activities of Cinoxacin.
Citric Acid
Ketoprofen may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Ketoprofen may increase the anticoagulant activities of Citric Acid.
Clobetasol
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clobetasol.
Clobetasol Propionate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clobetasol propionate.
Clobetasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clobetasone.
Clocortolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clocortolone.
Clodronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clodronic Acid.
Clonixin
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clonixin.
Clotrimazole
The metabolism of Ketoprofen can be decreased when combined with Clotrimazole.
Colesevelam
Colesevelam can cause a decrease in the absorption of Ketoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Ketoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cortisone Acetate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Cortisone acetate.
Crisaborole
The metabolism of Ketoprofen can be decreased when combined with Crisaborole.
Curcumin
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Cyclopenthiazide can be decreased when used in combination with Ketoprofen.
Cyclosporine
Ketoprofen may increase the nephrotoxic activities of Cyclosporine.
Dabigatran Etexilate
Ketoprofen may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Ketoprofen can be decreased when it is combined with Dabrafenib.
Dalteparin
Ketoprofen may increase the anticoagulant activities of Dalteparin.
Danaparoid
Ketoprofen may increase the anticoagulant activities of Danaparoid.
Daunorubicin
Ketoprofen may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Deferasirox
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Deferasirox.
Deflazacort
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Deflazacort.
Delavirdine
The metabolism of Ketoprofen can be decreased when combined with Delavirdine.
Desirudin
Ketoprofen may increase the anticoagulant activities of Desirudin.
Desmopressin
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Desmopressin.
Desonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Desonide.
Desoximetasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Desoximetasone.
Desoxycorticosterone acetate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Desoxycorticosterone Pivalate.
Dexamethasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Dexamethasone.
Dexketoprofen
The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Ketoprofen.
Dextran
Ketoprofen may increase the anticoagulant activities of Dextran.
Dextran 40
Ketoprofen may increase the anticoagulant activities of Dextran 40.
Dextran 70
Ketoprofen may increase the anticoagulant activities of Dextran 70.
Dextran 75
Ketoprofen may increase the anticoagulant activities of Dextran 75.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Ketoprofen.
Dicumarol
Ketoprofen may increase the anticoagulant activities of Dicoumarol.
Diflorasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Diflorasone.
Diflucortolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Difluocortolone.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Ketoprofen.
Difluprednate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Difluprednate.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Ketoprofen.
Dihydrostreptomycin
Ketoprofen may decrease the excretion rate of Dihydrostreptomycin which could result in a higher serum level.
Dinoprost
The therapeutic efficacy of Dinoprost can be decreased when used in combination with Ketoprofen.
Dinoprost Tromethamine
The therapeutic efficacy of Dinoprost Tromethamine can be decreased when used in combination with Ketoprofen.
Dinoprostone
The therapeutic efficacy of Dinoprostone can be decreased when used in combination with Ketoprofen.
Dipyrone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Metamizole.
Dothiepin
The metabolism of Ketoprofen can be decreased when combined with Dosulepin.
Doxorubicin
Ketoprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Doxorubicin Hydrochloride
Ketoprofen may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Drospirenone
Ketoprofen may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Droxicam.
Edetic Acid
Ketoprofen may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Ketoprofen may increase the anticoagulant activities of Edoxaban.
Efavirenz
The metabolism of Ketoprofen can be decreased when combined with Efavirenz.
Enalapril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Enalaprilat.
Enoxacin
Ketoprofen may increase the neuroexcitatory activities of Enoxacin.
Enoxaparin
Ketoprofen may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Ketoprofen may increase the anticoagulant activities of Enoxaparin.
Epirubicin
Ketoprofen may decrease the excretion rate of Epirubicin which could result in a higher serum level.
Eplerenone
Ketoprofen may decrease the antihypertensive activities of Eplerenone.
Epoprostenol
The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Ketoprofen.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Ketoprofen.
Esmolol
Ketoprofen may decrease the antihypertensive activities of Esmolol.
Estrone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Ketoprofen.
Ethacrynate
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Ketoprofen.
Ethacrynic Acid
The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Ketoprofen.
Ethylenediaminetetraacetate
Ketoprofen may increase the anticoagulant activities of Edetic Acid.
Etidronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etidronic acid.
Etidronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etidronic acid.
Etodolac
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Etoricoxib.
Etravirine
The metabolism of Ketoprofen can be decreased when combined with Etravirine.
Evening primrose oil
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Evening primrose oil.
Felbinac
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Felbinac.
Fenbufen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fenbufen.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Ketoprofen.
Ferulic Acid
Ketoprofen may increase the anticoagulant activities of Ferulic acid.
Fleroxacin
Ketoprofen may increase the neuroexcitatory activities of Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Ketoprofen.
Floxuridine
The metabolism of Ketoprofen can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Ketoprofen can be decreased when combined with Fluconazole.
Fludrocortisone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fludrocortisone.
Fluindione
Ketoprofen may increase the anticoagulant activities of Fluindione.
Flumequine
Ketoprofen may increase the neuroexcitatory activities of Flumequine.
Flumethasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Flumethasone.
Flunisolide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Flunisolide.
Flunisolide Anhydrous (obsolete)
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Flunisolide.
Fluocinolone Acetonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluocinolone Acetonide.
Fluocinonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluocinonide.
Fluocortolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluocortolone.
Fluorometholone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluorometholone.
Fluorouracil
The metabolism of Ketoprofen can be decreased when combined with Fluorouracil.
FLUPREDNIDENE
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluprednidene.
Fluprednisolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluprednisolone.
Flurandrenolide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Flurandrenolide.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Ketoprofen.
Fluticasone Furoate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluticasone furoate.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Ketoprofen can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Ketoprofen can be decreased when combined with Fluvoxamine.
Folate
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Ketoprofen.
Folic Acid
The therapeutic efficacy of Folic Acid can be decreased when used in combination with Ketoprofen.
Fondaparinux
Ketoprofen may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Ketoprofen may increase the anticoagulant activities of Fondaparinux sodium.
Formestane
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Formestane.
Fosinopril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fosinopril.
Fosphenytoin
The metabolism of Ketoprofen can be increased when combined with Fosphenytoin.
Framycetin
Ketoprofen may decrease the excretion rate of Framycetin which could result in a higher serum level.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Ketoprofen.
Gatifloxacin
Ketoprofen may increase the neuroexcitatory activities of Gatifloxacin.
Gatifloxacin Anhydrous
Ketoprofen may increase the neuroexcitatory activities of Gatifloxacin.
Gemeprost
The therapeutic efficacy of Gemeprost can be decreased when used in combination with Ketoprofen.
Gemfibrozil
The metabolism of Ketoprofen can be decreased when combined with Gemfibrozil.
Gemifloxacin
Ketoprofen may increase the neuroexcitatory activities of Gemifloxacin.
Gemifloxacin Mesylate
Ketoprofen may increase the neuroexcitatory activities of Gemifloxacin.
Gentamicin
Ketoprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Grepafloxacin
Ketoprofen may increase the neuroexcitatory activities of Grepafloxacin.
Halcinonide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Halcinonide.
Halobetasol
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ulobetasol.
Haloperidol
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Haloperidol.
Heparin
Ketoprofen may increase the anticoagulant activities of Heparin.
Hydralazine
Ketoprofen may decrease the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ketoprofen.
Hydrocortisone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Ketoprofen.
Ibandronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ibandronate.
Ibandronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ibandronate.
Ibuprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Icatibant.
Idarubicin
Ketoprofen may decrease the excretion rate of Idarubicin which could result in a higher serum level.
Iloprost
The therapeutic efficacy of Iloprost can be decreased when used in combination with Ketoprofen.
Imidapril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Imidapril.
Indapamide
The therapeutic efficacy of Indapamide can be decreased when used in combination with Ketoprofen.
Indinavir
The metabolism of Ketoprofen can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Ketoprofen can be decreased when combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Ketoprofen.
Irbesartan
The metabolism of Ketoprofen can be decreased when combined with Irbesartan.
Kanamycin
Ketoprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
kanamycin A
Ketoprofen may decrease the excretion rate of Kanamycin which could result in a higher serum level.
Kebuzone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Kebuzone.
Ketoconazole
The metabolism of Ketoprofen can be decreased when combined with Ketoconazole.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Ketoprofen.
Labetalol
Ketoprofen may decrease the antihypertensive activities of Labetalol.
Latanoprost
The therapeutic efficacy of Latanoprost can be decreased when used in combination with Ketoprofen.
Latanoprostene Bunod
The therapeutic efficacy of Latanoprostene Bunod can be decreased when used in combination with Ketoprofen.
Leflunomide
The metabolism of Ketoprofen can be decreased when combined with Leflunomide.
Lepirudin
Ketoprofen may increase the anticoagulant activities of Lepirudin.
Levobunolol
Ketoprofen may decrease the antihypertensive activities of Levobunolol.
Levofloxacin
Ketoprofen may increase the neuroexcitatory activities of Levofloxacin.
Levofloxacin Anhydrous
Ketoprofen may increase the neuroexcitatory activities of Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Ketoprofen is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Ketoprofen.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Ketoprofen.
Lornoxicam
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Lornoxicam.
Losartan
The metabolism of Ketoprofen can be decreased when combined with Losartan.
Loteprednol
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Loteprednol.
Lovastatin
The metabolism of Ketoprofen can be decreased when combined with Lovastatin.
Loxoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Loxoprofen.
Lubiprostone
The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Ketoprofen.
Lumacaftor
The serum concentration of Ketoprofen can be decreased when it is combined with Lumacaftor.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Magnesium salicylate.
Manidipine
The metabolism of Ketoprofen can be decreased when combined with Manidipine.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Ketoprofen.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ketoprofen.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ketoprofen.
Medronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Technetium Tc-99m medronate.
Medrysone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Medrysone.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Ketoprofen.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Ketoprofen.
Mesalamine
Ketoprofen may increase the nephrotoxic activities of Mesalazine.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Ketoprofen.
Methyclothiazide
The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Ketoprofen.
Methylprednisolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Methylprednisolone.
Metipranolol
Ketoprofen may decrease the antihypertensive activities of Metipranolol.
Metolazone
The therapeutic efficacy of Metolazone can be decreased when used in combination with Ketoprofen.
Metoprolol
Ketoprofen may decrease the antihypertensive activities of Metoprolol.
Metrizamide
Ketoprofen may decrease the excretion rate of Metrizamide which could result in a higher serum level.
Midostaurin
The metabolism of Ketoprofen can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Ketoprofen can be increased when it is combined with Mifepristone.
Misoprostol
The therapeutic efficacy of Misoprostol can be decreased when used in combination with Ketoprofen.
Moexipril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Moexipril.
Mometasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Mometasone.
Morniflumate
The risk or severity of adverse effects can be increased when Morniflumate is combined with Ketoprofen.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Mycophenolic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Ketoprofen.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Mycophenolic acid.
Nabumetone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Nabumetone.
Nadolol
Ketoprofen may decrease the antihypertensive activities of Nadolol.
Nadroparin
Ketoprofen may increase the anticoagulant activities of Nadroparin.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Ketoprofen.
Nalidixic Acid
Ketoprofen may increase the neuroexcitatory activities of Nalidixic Acid.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Ketoprofen.
Nebivolol
Ketoprofen may decrease the antihypertensive activities of Nebivolol.
Neomycin
Ketoprofen may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Ketoprofen.
Netilmicin
Ketoprofen may decrease the excretion rate of Netilmicin which could result in a higher serum level.
Nicardipine
The metabolism of Ketoprofen can be decreased when combined with Nicardipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Niflumic Acid.
Nimesulide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Nimesulide.
Norfloxacin
Ketoprofen may increase the neuroexcitatory activities of Norfloxacin.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Evening primrose oil.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Ketoprofen.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Ketoprofen.
Olsalazine
Ketoprofen may increase the nephrotoxic activities of Olsalazine.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Ketoprofen is combined with Omacetaxine mepesuccinate.
Omeprazole
The metabolism of Ketoprofen can be decreased when combined with Omeprazole.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Ketoprofen.
Oxprenolol
Ketoprofen may decrease the antihypertensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Oxyphenbutazone.
Pamidronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Pamidronate.
Pamidronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Pamidronate.
Paramethasone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Paramethasone.
Parecoxib
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Parecoxib.
Paromomycin
Ketoprofen may decrease the excretion rate of Paromomycin which could result in a higher serum level.
Parthenolide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Parthenolide.
Pefloxacin
Ketoprofen may increase the neuroexcitatory activities of Pefloxacin.
Penbutolol
Ketoprofen may decrease the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Ketoprofen may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentosan Polysulfate
Ketoprofen may increase the anticoagulant activities of Pentosan Polysulfate.
Perindopril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Perindopril.
Phenindione
Ketoprofen may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Ketoprofen can be increased when combined with Phenobarbital.
Phenprocoumon
Ketoprofen may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Ketoprofen.
Phenytoin
The metabolism of Ketoprofen can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ketoprofen.
Pindolol
Ketoprofen may decrease the antihypertensive activities of Pindolol.
Pirarubicin
Ketoprofen may decrease the excretion rate of Pirarubicin which could result in a higher serum level.
Piretanide
The therapeutic efficacy of Piretanide can be decreased when used in combination with Ketoprofen.
Pirfenidone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Ketoprofen.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Ketoprofen.
Plicamycin
Ketoprofen may decrease the excretion rate of Plicamycin which could result in a higher serum level.
Polythiazide
The therapeutic efficacy of Polythiazide can be decreased when used in combination with Ketoprofen.
Practolol
Ketoprofen may decrease the antihypertensive activities of Practolol.
Pralatrexate
The serum concentration of Pralatrexate can be increased when it is combined with Ketoprofen.
Prasterone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prasterone.
Prednicarbate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prednicarbate.
Prednisolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prednisolone.
Prednisone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Prednisone.
Pregnenolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Pregnenolone.
Primidone
The metabolism of Ketoprofen can be increased when combined with Primidone.
Probenecid
The serum concentration of Ketoprofen can be increased when it is combined with Probenecid.
Propranolol
Ketoprofen may decrease the antihypertensive activities of Propranolol.
protein C, human
Ketoprofen may increase the anticoagulant activities of Protein C.
protein S, human
Ketoprofen may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Ketoprofen may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Ketoprofen can be decreased when combined with Pyrimethamine.
Quinapril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Quinapril.
Quinethazone
The therapeutic efficacy of Quinethazone can be decreased when used in combination with Ketoprofen.
Quinine
The metabolism of Ketoprofen can be decreased when combined with Quinine.
Ramipril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ramipril.
Rescinnamine
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Rescinnamine.
Resveratrol
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Resveratrol.
Reviparin
Ketoprofen may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Ketoprofen may increase the anticoagulant activities of Reviparin.
Rifampin
The metabolism of Ketoprofen can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Ketoprofen can be increased when combined with Rifapentine.
Rimexolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Rimexolone.
Risedronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Risedronate.
Risedronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Risedronate.
Rivaroxaban
Ketoprofen may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Rofecoxib.
Rosoxacin
Ketoprofen may increase the neuroexcitatory activities of Rosoxacin.
Rucaparib
The metabolism of Ketoprofen can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Ketoprofen.
Salicylamide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Ketoprofen.
Salsalate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Salsalate.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Ketoprofen.
Sarilumab
Sarilumab may increase the immunosuppressive activities of Ketoprofen.
Secobarbital
The metabolism of Ketoprofen can be increased when combined with Secobarbital.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Serrapeptase.
Sildenafil
The metabolism of Ketoprofen can be decreased when combined with Sildenafil.
Sisomicin
Ketoprofen may decrease the excretion rate of Sisomicin which could result in a higher serum level.
Sodium Phosphate
Sodium phosphate may increase the nephrotoxic activities of Ketoprofen.
Sodium Phosphate, Monobasic
Sodium phosphate may increase the nephrotoxic activities of Ketoprofen.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Sodium phosphate may increase the nephrotoxic activities of Ketoprofen.
Sorafenib
The metabolism of Ketoprofen can be decreased when combined with Sorafenib.
Sotalol
Ketoprofen may decrease the antihypertensive activities of Sotalol.
Sparfloxacin
Ketoprofen may increase the neuroexcitatory activities of Sparfloxacin.
Spectinomycin
Ketoprofen may decrease the excretion rate of Spectinomycin which could result in a higher serum level.
Spirapril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Spirapril.
Spironolactone
Ketoprofen may decrease the antihypertensive activities of Spironolactone.
Streptomycin
Ketoprofen may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Streptozocin
Ketoprofen may decrease the excretion rate of Streptozocin which could result in a higher serum level.
Sulfadiazine
The metabolism of Ketoprofen can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Ketoprofen can be decreased when combined with Sulfamethoxazole.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Ketoprofen.
Sulfisoxazole
The metabolism of Ketoprofen can be decreased when combined with Sulfisoxazole.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Ketoprofen.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Ketoprofen.
Tacrolimus
Ketoprofen may increase the nephrotoxic activities of Tacrolimus.
Tafluprost
The therapeutic efficacy of Tafluprost can be decreased when used in combination with Ketoprofen.
Talinolol
Ketoprofen may decrease the antihypertensive activities of Talinolol.
Talniflumate
The risk or severity of adverse effects can be increased when Talniflumate is combined with Ketoprofen.
Technetium Tc 99m Medronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Technetium Tc-99m medronate.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Ketoprofen.
Temafloxacin
Ketoprofen may increase the neuroexcitatory activities of Temafloxacin.
Tenofovir Disoproxil
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tenofovir disoproxil.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Ketoprofen.
Teriflunomide
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Teriflunomide.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tiaprofenic acid.
Ticagrelor
The metabolism of Ketoprofen can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Ketoprofen can be decreased when combined with Ticlopidine.
Tiludronate
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tiludronic acid.
Tiludronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tiludronic acid.
Timolol
Ketoprofen may decrease the antihypertensive activities of Timolol.
Timolol Anhydrous
Ketoprofen may decrease the antihypertensive activities of Timolol.
Tixocortol
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tixocortol.
Tobramycin
Ketoprofen may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tolbutamide
The metabolism of Ketoprofen can be decreased when combined with Tolbutamide.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Ketoprofen.
Torsemide
The therapeutic efficacy of Torasemide can be decreased when used in combination with Ketoprofen.
Trandolapril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Tranilast.
Travoprost
The therapeutic efficacy of Travoprost can be decreased when used in combination with Ketoprofen.
Treprostinil
The risk or severity of adverse effects can be increased when Treprostinil is combined with Ketoprofen.
Triamcinolone
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Triamcinolone.
Triamterene
Ketoprofen may decrease the antihypertensive activities of Triamterene.
Trichlormethiazide
The therapeutic efficacy of Trichlormethiazide can be decreased when used in combination with Ketoprofen.
Trimethoprim
The metabolism of Ketoprofen can be decreased when combined with Trimethoprim.
Trovafloxacin
Ketoprofen may increase the neuroexcitatory activities of Trovafloxacin.
Troxerutin
Ketoprofen may increase the anticoagulant activities of Troxerutin.
UNOPROSTONE
The therapeutic efficacy of Unoprostone can be decreased when used in combination with Ketoprofen.
Valdecoxib
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Valdecoxib.
Valproate
The metabolism of Ketoprofen can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Ketoprofen can be decreased when combined with Valproic Acid.
Valrubicin
Ketoprofen may decrease the excretion rate of Valrubicin which could result in a higher serum level.
Valsartan
The metabolism of Ketoprofen can be decreased when combined with Valsartan.
Vancomycin
The serum concentration of Vancomycin can be increased when it is combined with Ketoprofen.
Voriconazole
The metabolism of Ketoprofen can be decreased when combined with Voriconazole.
Warfarin
Ketoprofen may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Ketoprofen can be decreased when combined with Zafirlukast.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Ketoprofen.
Zofenopril
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zofenopril.
Zoledronic Acid
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zoledronic acid.
Zoledronic Acid Anhydrous
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zoledronic acid.
Zomepirac
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zomepirac.
